Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03713593 |
|---|---|
| Brief Title: | Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002) |
| First Submitted : | October 18, 2018 |
| First Submitted that Met QC Criteria : | October 18, 2018 |
| First Posted : | October 22, 2018 |
| Results First Submitted : | June 8, 2023 |
| Results First Posted with QC Comments : | June 28, 2023 |
| Results First Submitted that Met QC Criteria : | July 21, 2023 |
| Results First Posted : | July 24, 2023 |
| Last Update Submitted that Met QC Criteria : | January 5, 2024 |
| Last Update Posted : | January 10, 2024 |